Abstract Previously, we characterized a gene encoding the unique nuclease (LdNuc s ) from a Sudanese isolate of the human pathogen Leishmania donovani. This parasite secretory enzyme is involved in the salvage of host-derived purines and is constitutively expressed by both developmental forms of the parasite. Currently, we assessed whether an LdNuc s -like nuclease was conserved among other geographically disparate isolates of L. donovani and whether this enzyme was produced by intracellular amastigotes during human infections. Using RT-PCR and Southern blotting, we showed that LdNuc s gene homologs were present in each of the viscerotropic Leishmania tested (i.e., L. donovani isolates from the Sudan, Ethiopia and India as well as L. infantum). Further results of in situ enzyme activity gel analyses showed that each of these parasite isolates also expressed a released/secreted LdNuc s -like nuclease activity. In Western blots, our anti-LdNuc s (Sudan) peptide-specific antibody reacted with only a single *35 kDa protein in each of the viscerotropic Leishmania isolates. Further, the *35 kDa nuclease secreted by each of these isolates was specifically immunoprecipitated by the anti-LdNuc s antibody above. In situ gel analyses showed that each of these immunoprecipitates had LdNuc slike nuclease activity. Moreover, sera from acute visceral leishmaniasis patients from India, Sudan and Brazil all immunoprecipitated an LdNuc s -HA expressed nuclease demonstrating, that these patients possessed antibodies against this parasite secretory enzyme. Cumulatively, these results showed that the LdNuc s homologs were functionally conserved among geographically disparate visceral Leishmania spp. and that amastigotes of these parasites must produce this nuclease enzyme during the course of human disease.
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Keywords Leishmania Á Protozoan pathogen Á Human parasite Á Nuclease Á Secretory enzyme Á Purine salvage Á Zymograms It is essential to point out that Leishmania spp., like other trypanosomatid parasites, are purine auxotrophs (i.e., incapable of de novo purine biosynthesis) [4, 5] . Thus in order to survive, Leishmania parasites must salvage these essential nutrients from their host environments. In that context, recently we identified a gene encoding a unique *35 kDa, DTT-sensitive, nuclease (LdNuc s ) from L. donovani (Ld 1S-CL2D; a causative agent of visceral disease in the Sudan). Based on the conservation of five unique structural domains, Pfam analysis of the LdNuc s showed that it belongs to the P1/S1 family of Class-I secretory fungal nucleases. The prototypical members of this family are the P1 and S1 nucleases of Penicillium and Aspergillus, respectively [6] . As with other members of the P1/S1 family, we showed that this enzyme was constitutively secreted in vitro by promastigotes and amastigotes of this eukaryotic human pathogen. Homologous episomal expression of an HA-tagged LdNuc s chimeric construct was used to delineate the functional and biochemical properties of this unique 35 kDa parasite released/secreted enzyme. Using this system, we had shown that this parasite nuclease could hydrolyze a variety of synthetic polynucleotides as well as several natural nucleic acid substrates including RNA, single stranded-DNA and double stranded-DNA suggesting that it may play a critical role in purine salvage pathways in these organisms. Based on these observations, it was deemed of interest to ascertain whether LdNuc s homologs were present in other geographic isolates of Leishmania spp. To that end, isolates of L. donovani from Ethiopia, India and an L. infantum isolate from Israel were subjected to RT-PCR and Southern blot hybridization using the LdNuc s gene as a probe. In addition, cell-free culture supernatants from each of these parasite isolates were also assayed for their release/secretion of a *35 kDa nuclease activity. Further, lysates as well as cell-free culture supernatants from these parasites were analyzed for their reactivity in Western blots and immunoprecipitation experiments with an antiLdNuc s antibody [6] to determine whether these parasite isolates possess antigenically related nucleases. Previously, we showed that promastigotes episomally transfected with an LdNuc-HA chimera constitutively secreted a functionally active LdNuc-HA enzyme into their culture supernatants [6] . In that regard, sera from patients acutely infected with visceral Leishmania were tested to determine whether they possess antibodies that would immunoprecipitate the LdNuc s -HA chimeric protein.
The presence of such antibodies would indicate that in vivo amastigotes synthesized an LdNuc s -like enzyme during the course of human leishmanial infections.
Materials and methods

Parasite cell lines and growth
The parasite cell lines used in this study were as follows: L. donovani strain 1S-CL2D, WHO designation: (MHOM SD/62/1S/1S-CL2D) originally isolated from a patient in Sudan; L. donovani strain LRC-751 (MHOM/IN/93/BI 2302/LRC-751) isolated from a patient in India; L. donovani strain LV9, (MHOM/ET/67/L82/LV9/WR684) isolated from a patient in Ethiopia; and L. infantum, LRC-639 (MCAN/IL/94/Robi/LRC-639) isolated from a dog with visceral leishmaniasis in Israel. For some experiments, an L. donovani (strain 1S-CL2D) parasite line transfected with the LdNuc s ::HA chimeric construct which secretes a hemagglutinin-tagged LdNuc s secretory nuclease (designated here as: LdNuc s -HA) was also used in these studies [6] . Promastigote forms of all wild-type parasite cell lines were routinely grown and maintained in medium M-199 (Gibco, Invitrogen Corp., Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS, Gemini Bio-Products, Woodland, CA, USA) as described previously [7] . The LdNuc s -HA transfected cell line was also grown in medium as above but supplemented with 100 lg/ml of Geneticin Ò (G418, Invitrogen).
Parasite cell lysates
Promastigotes of each parasite line were grown to *midlog phase as above, and harvested by centrifugation at *2,1009g for 15 min at 4°C [8] . The resulting cell pellets were washed thrice in ice-cold phosphate-buffered saline (PBS, 10 mM sodium phosphate, 145 mM NaCl, pH 7.4) by centrifugation as above and finally solubilized in SDS-PAGE sample buffer [9] lacking any reducing agents. Such samples were heated in a boiling water bath for 5 min, cooled to room temperature, frozen and stored at -80°C until analyzed. The protein concentration in these cell lysates was determined using the bicinchoninic acid method according to manufacturer's instructions (Micro BCA, Pierce Biotechnology Inc./Thermo Scientific Rockford, IL, USA).
Generation of cell-free culture supernatants
For some experiments, the wild-type promastigotes were grown in serum-free, chemically defined medium (M199?) according to [7, 10] . The LdNuc s -HA transfected parasite line [6] was also grown in such medium but supplemented with 100 lg/ml of G418 (Invitrogen/Life Technologies Inc.). All of these parasite lines were cultured at 26°C until they reached *1-2910 7 cells/ml (i.e., mid-log phase) and were examined by phase contrast microscopy to ensure [99.9% cell viability. Subsequently, such cells were harvested by centrifugation at *2,1009g for 15 min at 4°C as described previously [8] . Following an additional high-speed re-centrifugation step, to ensure the complete pelleting of cells [8] , the cell-free culture supernatants were carefully removed, frozen and stored at -80°C until used. Such parasite culture supernatants were also concentrated up to *100-fold (1009) using Centricon Ò Plus-20 centrifugal filtration devices as per manufacturer's recommendations (Amicon BioSeparations, Millipore Corp., Billerica, MA, USA). These concentrated samples were assayed for their nuclease activity using SDS-PAGE poly (A) containing zymogram gels [6] . In addition, aliquots of parasite culture supernatants were also assayed for their nuclease activity following binding to nucleotide-dye mimetic bead matrices (i.e., Reactive Red agarose, SigmaAldrich) as described below.
Binding of leishmanial nuclease activities to affinity matrices
In preliminary experiments, several affinity bead matrices (Reactive Red agarose, Sigma-Aldrich. St. Louis, MO, USA); Cibacron Blue F3G-A Sepharose, GE Healthcare Bio-Sciences Piscataway, NJ, USA) were tested for their ability to bind the 35-kDa nuclease activity released/ secreted by L. donovani promastigotes grown in serumfree, chemically defined M199 ? medium, above. Cibacron Blue and Reactive Red dye-affinity matrices were used based on their reported abilities [11] [12] [13] to bind proteins with affinities for various nucleotides (e.g., restriction endonucleases and NADP-dependent dehydrogenases, respectively). Prior to use in assays, these affinity bead matrices (100 ll packed volume) were washed four times in 1 ml volumes each of PBS, containing 10 mM HEPES, 0.1% (v/v) Triton X-100 (Protein Grade Ò , Calbiochem, EMD Biosciences, Inc. La Jolla, CA, USA) and 25 lg/ml leupeptin (Sigma-Aldrich), pH 7.2 by microfuge centrifugation (1 min each at *13,0009g). For assays, 10 ml of cell-free parasite culture supernatants above were reacted with 100 ll (packed volume) of pre-washed affinity beads as above on a platform rocker for 4 h at 4°C. Subsequently, the beads were pelleted by microfuge centrifugation and the supernatants were discarded. The pelleted beads were washed four times (1 ml each) with the buffer above and once in the same buffer minus Triton X-100 by microfuge centrifugation. Finally, the washed beads were resuspended in 50 ll of 19 SDS-PAGE sample buffer [9] lacking any reducing agents and heated in a boiling water bath for 5 min and cooled to room temperature. Following microfuge centrifugation to pellet the beads, aliquots of the supernatants were assayed for their nuclease activity by in situ nuclease gel assays as described below.
In situ nuclease zymogram assays
In situ nuclease activity gels were used to evaluate the nuclease activity present in concentrated cell-free culture supernatants, samples eluted from Reactive Red agarose beads (above) and immunoprecipitates obtained with both rabbit anti-LdNuc s peptide antibody and VL-patient sera as described below. Briefly, aliquots of samples prepared in SDS-PAGE sample buffer (lacking reducing agent) were separated in 10% SDS-PAGE gels containing poly (A) (Sigma-Aldrich, 300 lg/m1, final concentration) as substrate. Following separation, gels were washed at room temperature with four changes (15 min ea.) of a denaturation buffer [100 mM HEPES, 0.1% (v/v) Triton X-100 (Protein Grade Ò Detergent, Calbiochem, EMD Biosciences, Inc., La Jolla, CA, USA), pH 8.5] and then incubated in the same buffer for 2 h at 37°C with gentle agitation. Subsequently, gels were rinsed, fixed with 7.5% (v/v) aqueous acetic acid, washed and stained with Toluidine Blue O [6] . Following destaining with multiple changes of deionized water, the nuclease activity in such gels was readily visible as clear/colorless bands of substrate hydrolysis in an otherwise uniformly stained, dark blue background of unhydrolyzed poly (A) substrate. Digital images of such gels were captured using a Nikon CoolPix 4500 camera (Nikon Corporation, Tokyo, Japan) and processed using Adobe Photo Shop 5.5 (Adobe Systems, Inc.).
Sera
The human sera used in the current study were obtained from patients clinically diagnosed with acute visceral leishmaniasis (VL) from three separate endemic foci (i.e. Sudan, India and Brazil). Sera from the same geographic area were pooled (each pool contained equal volumes obtained from 8 to 10 individual VL-patients) as described previously [14] . Similarly, the pools of normal human sera (NHS) obtained from North American volunteers and from uninfected volunteers within endemic foci were described previously [14] and used as controls in the current report.
In addition, a rabbit anti-LdNuc s antibody generated against a synthetic peptide corresponding to amino acid residues 157-172 of the LdNuc s deduced protein from the 1S-CL2D Sudan strain of L. donovani [6] was also used in this study. This antibody was shown to recognize both the 35-kDa native/wild-type secretory enzyme and the HAtagged, episomally expressed LdNuc s nuclease in parasite cell lysates and cell-free culture supernatants. A preimmune serum from this rabbit (NRS) was used as a control. For some Western blot experiments, a rabbit antihemagglutinin (a-HA) antibody (Sigma-Aldrich, Corp., St. Louis, MO, USA) was used in conjunction with an NRS control.
Western blot analysis
Parasite cell lysates (25 lg protein each), were separated in SDS-PAGE gels (10%, pre-cast, Tris-glycine polyacrylamide, Novex Ò gels, Invitrogen) and subsequently transblotted onto PVDF (polyvinylidene diflouride) membranes as described previously [15] . Such membranes were blocked with 5% (w/v) nonfat powdered milk in a buffer containing 0.05% (v/v) Tween-20, 20 mM Tris-HCl, 150 mM NaCl, pH 8.0 and probed with an anti-LdNuc s peptide antibody [6] or its NRS control. Following incubation and washing, the blots were reacted with donkey anti-rabbit-horseradish peroxidase (HRP)-conjugated secondary antibody (GE Healthcare Bio-Sciences Corp.). Immunodetection was carried out using the ECL Western Blot Kit reagents as per manufacturer's recommendations (GE Healthcare Bio-Sciences Corp.). Images from such blots were captured using BIOMAX TM -MR X-ray film (Eastman Kodak, Rochester, NY, USA) and processed using Adobe Photoshop 5.5 (Adobe Systems Inc.).
Immunoprecipitation reactions
Reactivity of parasite released/secreted nucleases with an anti-LdNuc s antibody
Immunoprecipitation (IP) experiments were carried out to determine whether the nuclease activity released/secreted by the various parasite lines (as determined above) was antigenically related to that described for the L. donovani (1S-CL2D) secretory nuclease [6] . To that end, cell-free culture supernatants from each of the parasite lines was reacted in IP buffer [50 mM Tris-HCl, 150 mM NaCl and 0.1% (v/v) Nonidet NP-40 (Sigma) pH7.4] with our rabbit anti-LdNuc s peptide antibody or NRS controls in combination with Protein A/G agarose beads (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) as described previously [6] . Following incubation at 4°C for 4 h, beads were pelleted by centrifugation, washed thrice with IPbuffer and twice with 50 mM Tris-HCl, pH 7.4. Subsequently, the bead-bound immunoprecipitates were eluted with SDS-PAGE sample buffer (lacking reducing agents) and heated in a boiling water bath for 5 min. The resulting samples were analyzed for their nuclease activity using SDS-PAGE-poly (A) zymogram gels as described above.
Reactivity of LdNuc
s -HA chimeric nuclease by VL-patient's sera Sera of acutely infected visceral leishmaniasis patients from several distinct endemic geographic foci (i.e., Sudan, India and Brazil) were tested to ascertain whether they possessed antibodies which could react with/recognize and immunoprecipitate the L. donovani (1S-CL2D)-released/ secreted (LdNuc s ) nuclease. To that end, L. donovani (Sudan, 1S-CL2D) promastigotes episomally transfected with the LdNuc s -HA chimeric protein was grown in chemically defined medium. Cell-free culture supernatants of these were reacted with individual pools of visceral leishmaniasis patient sera from Sudan, India and Brazil or with NHS controls in a Protein A-bead-based immunoprecipitation assay essentially as described above. Immunoprecipitates captured on the Protein A-Sepharose beads (GE Health Care) were washed, eluted and analyzed in zymogram gels as well as, in Western blots using anti-HA antibody all as above.
DIG labeled probe
A digoxigenin-labeled probe (LdNuc s -DIG950) corresponding to the complete open reading frame (ORF) of the L. donovani (1S-CL2D) released/secreted nuclease (LdNuc s ), was generated using digoxigenin-dUTP and the PCR DIG Labeling Kit (Roche Diagnostics, Indianapolis, IN, USA) all as described previously [6] . This LdNuc s -DIG950 probe was subsequently used in Southern blot experiments.
Isolation of genomic DNA and Southern blot analyses gDNA was isolated from log phase promastigotes of each parasite cell line using the Wizard Ò Genomic DNA purification kit (Promega Corporation, Madison, WI, USA) according to manufacturer's recommendations. For Southern blot analyses, such gDNA(s) were digested with Bam HI or Spe I restriction endonucleases, separated in 1% agarose gels, transferred onto positively charged Nylon membranes (Roche) and cross-linked to the membranes by UV irradiation using a Stratalinker Ò 2400 (Stratagene La Jolla, CA, USA). Such membranes were hybridized (under high stringency conditions) using the digoxigenin-labeled LdNuc s -DIG950 probe. Subsequently blots were washed at high stringency (0.19 SSC, 0.1% SDS at 65°C), and the hybridized fragments visualized using an anti-digoxigeninalkaline phosphatase-conjugated antibody in conjunction with a chemiluminescent detection reagent (CSPD) as per manufacturer's instructions (Roche). Images from such blots were captured using BIOMAX TM -MR X-ray film (Kodak) and processed using Adobe Photoshop 5.5 (Adobe Systems Inc.).
Isolation of RNA and RT-PCR analysis
Total RNA was isolated from log phase promastigotes of each parasite cell line using RNA STAT-60 according to the manufacturer's recommendations (Tel-Test Inc., Friendswood, TX, USA). Such RNAs were treated with DNase (Qiagen Inc., Valencia, CA, USA) to obviate any potential DNA contamination and used subsequently in RT reactions. Aliquots of total RNA (1 lg) were used to generate cDNA using the GeneAmp RNA PCR kit and Oligo d (T) 16 The resulting PCR-amplified products obtained from these reactions were separated in 1.2% agarose gels (E-Gels, Invitrogen Carlsbad, CA, USA); visualized using a UVPBiochemi Imaging System (UVP-Bioimaging Systems, UVP Inc., Upland, CA, USA) and the images processed using Adobe Photoshop 5.5 (Adobe Systems Inc.).
To confirm the identity of the RT-PCR amplified products they were cloned into the pCR Ò 2.1-TOPO plasmid vector and subjected to nt-sequencing using the vector encoded M13-forward and -reverse primers (Invitrogen). Sequence data obtained from each RT-PCR product was analyzed and compared using the ClustalW program in a MacVector7 Software package (Accelrys, San Diego, CA, USA). In addition, these RT-PCR products were also separated in 1% agarose gels and subjected to Southern Blot analysis using the LdNuc s -DIG950 probe under high stringency conditions as above.
Results
Identification of LdNuc s nuclease gene homologs
Recently, we identified and characterized a gene (LdNuc s ) encoding the unique secretory/released nuclease from the human pathogen, L. donovani. This gene and its encoded nuclease were functionally and biochemically characterized from a clone derived from a parasite isolated from a visceral leishmaniasis patient in Sudan [6] . In light of those observations, it was deemed of interest to determine whether homologous genes might also be present in other diverse geographic isolates of L. donovani (i.e., those obtained from different endemic foci). A L. infantum strain was also included in this study as it is a closely related (congeneric) species capable of causing visceral leishmaniasis in humans. In the current study, gDNA from several different isolates of L. donovani as well as from L. infantum were digested individually with BamH I or Spe I restriction endonucleases, subjected to Southern blotting and hybridization using a DIG-labeled LdNuc s -specific gene probe at high stringency. Results obtained with this probe and the gDNA from the homologous Sudan, 1S-CL2D parasites (Fig. 1, lanes 1 and 2) are in full agreement with those reported previously [6] . Interestingly, similar hybridization results were also obtained with this probe and BamH I-digested gDNA from the Ethiopian and Indian isolates of L. donovani and from L. infantum (cf. Fig. 1,  lanes: 1, 3, 5 and 7) . Similarly, the LdNuc s -specific gene probe also hybridized with comparable-sized fragments of Spe I digested gDNA obtained from each of the parasite lines tested (cf. Fig. 1, lanes: 2, 4, 6 and 8) .
Taken together, results of these Southern blot analyses indicated that an LdNuc s gene homolog was present in/ conserved among the several different geographic isolates of L. donovani tested as well as, in the congeneric L. infantum parasites.
Expression of LdNuc s transcripts in various parasite isolates
In light of the results above, it was of interest to determine whether these LdNuc s gene homologs were, indeed, transcribed into mature mRNA by each of these parasites cell lines. To examine this, RT-PCR analyses were performed. It is important to point out that in trypanosomatid parasites; all of their mature, translatable mRNAs are capped at the 5 0 -end with a conserved 39 nt, ''spliced-leader'' (SL), sequence [17, 18] . For these experiments, cDNAs were reverse-transcribed from the total RNAs isolated from each of the parasite cell lines. Aliquots of such cDNAs were used as template in PCR amplifications with a 5 0 -forward primer corresponding to a portion of the spliced leader sequence (i.e., SpliceFwd, above) and a reverse primer corresponding to an internal sequence in the LdNuc s ORF (i.e., RTRev, above). Results of these RT-PCR analyses showed that a *540 bp product was amplified using RNA obtained from each of the geographic isolates of L. donovani, i.e., Sudan, Ethiopia, and India (Fig. 2, lanes 1-3, respectively) as well as from L. infantum (Fig 2, lane 4) . These results indicated that each of these parasite cell lines did, in fact, transcribe a mature mRNA from their LdNuc s gene homologs. Such RT-PCR products were also subjected to Southern blot analyses using the LdNuc s ORFspecific probe. In these blots, the DIG-labeled LdNuc s probe hybridized (under high stringency conditions) with each of the *540 bp RT-PCR products indicating, that they all contained a portion of the LdNuc s ORF (data not shown).
To further confirm the identity of the RT-PCR products above, each of them were cloned and subjected to ntsequencing. Comparisons of these sequences by ClustalW analyses showed that they had *99% identity with each other (Fig. 3) . Further, these analyses also showed that the start codon (i.e., the first ATG) in each of the amplified sequences was highly conserved and that it was preceded by 315 nt of 5 0 -UTR in each of the parasite isolates analyzed.
The cumulative results of these analyses demonstrated that the LdNuc s gene homologs present in each of these parasite isolates was in fact transcribed into a mature mRNA. Thus, our results suggest that this gene was highly conserved among all of the viscerotropic Leishmania spp. examined here despite their geographic dispersion and isolation from each other.
Detection of nuclease activity released by parasites during their growth in vitro
Since the LdNuc s nuclease was shown to be constitutively released/secreted by the Sudanese strain of L. donovani [6] , it was of interest to determine whether similar nuclease activity was also released/secreted by the various other viscerotropic parasites examined in this report. In that regard, previously we found that the LdNuc s nuclease would readily bind to the dye-mimetic bead matrix, ''Reactive Red agarose''. Based on those observations, cellfree culture supernatants from each of the parasite cell lines were reacted with Reactive Red agarose beads. Subsequently, bead-bound proteins were eluted and analyzed for (Fig. 4, lane 1) . Further, such activity was completely abrogated by pretreatment of these samples with DTT (data not shown). These results are in full agreement with our previous observations [6] . In parallel, similar Reactive Red bead eluates obtained from culture supernatants of both the Ethiopian and Indian strains of L. donovani as well as those from L. infantum parasites all possessed a similar single *35 kDa band of nuclease activity (cf. Fig. 4, lanes 2-4, respectively) . Further, it is of significance to point out that the *35 kDa secretory nuclease activities present in each of those samples was also abolished following treatment with the disulfide reducing agent, DTT (data not shown). In addition, identical results to those above were also obtained in zymogram assays using Cibacron Blue beads as an adsorbent for the parasite nuclease or those employing culture supernatant samples concentrated to *100-fold using centrifugal filtration devices (Centricon Ò , Millipore Bedford, MA, USA) (data not shown).
Taken together, results of these experiments demonstrated that each of these viscerotropic parasites appeared to release/secrete a single *35 kDa functional nuclease enzyme into their culture supernatants during their growth in vitro. Further, like the prototype LdNuc s (i.e., from the 1S-CL2D, Sudanese strain of L. donovani), each of these released/secretory nucleases also appeared to be completely inhibited by treatment with DTT. These observations further underscore the apparent functional conservation of this secretory enzyme among these diverse geographically distinct parasite isolates.
Western blot detection of LdNuc s nuclease homologs
Having demonstrated that each of the visceral parasite strains produced a mature message for the LdNuc s homolog, it was of interest to determine whether such mature messages were actually translated into an LdNuc s -like To test this, cell lysates from each of the parasite lines were separated in SDS-PAGE gels and reacted in Western blots with the anti-LdNuc s peptide antibody or its NRS control [6] . As anticipated in such blots, the antiLdNuc s antibody reacted with only a single *35 kDa protein present in lysates of the homologous strain of L. donovani (1S-CL2D, Sudan) parasites (Fig. 5, lane 1) . Interestingly, this antibody also reacted with a single, similarly sized (*35 kDa) protein present in lysates of both the Ethiopian and Indian strains of L. donovani (Fig. 5, lanes 2 and 3, respectively) . In addition, the antiLdNuc s antibody showed strong reactivity with a single *35 kDa protein present in the lysates of the congeneric, L. infantum parasites (Fig. 5, lane 4) . In parallel blots, preimmune serum (NRS) from this rabbit showed no reactivity with any of these parasite samples (data not shown). Results of these Western blot experiments showed that the LdNuc s gene homolog present in each of these parasite isolates was in fact translated into a 35-kDa protein which appeared to share common, structurally conserved, antigenic epitopes with those present in the ''prototype'' LdNuc s nuclease from the 1S-CL2D, Sudan strain of L. donovani.
Immunoprecipitation of parasite released/secreted nuclease activity with anti-LdNuc s antibody
Results of our Western blot experiments above demonstrated that the anti-LdNuc s -peptide antibody reacted with a single *35 kDa protein present in lysates from each of the parasite strains tested. In light of this, it was relevant to determine whether this antibody would recognize and immunoprecipitate the *35 kDa, DTT-sensitive nuclease activities released/secreted by the various viscerotropic parasite lines. For those experiments, cell-free culture supernatants from each of the parasite lines were reacted with the anti-LdNuc s peptide antibody or control NRS in a protein A/G-agarose bead-based assay [6] . The resulting bead-bound immunoprecipitates were solubilized in SDS-PAGE sample buffer lacking any reducing agents. Subsequently, these samples were analyzed for their nuclease activity in SDS-PAGE zymogram gels containing poly (A) as substrate. Consistent with the previous findings [6] , (Fig. 6, lane 1) . It is of significance that this antibody also immunoprecipitated a single *35 kDa nuclease activity present in the culture supernatants of both the Ethiopian and Indian strains of L. donovani (Fig. 6, lanes 2 and 3, respectively) as well as that of L. infantum (Fig. 6, lane 4) . Further, it is of relevance to point out that the nuclease activity present in each of these immunoprecipitates was completely abrogated when they were eluted with sample buffer containing DTT (data not shown). In these immunoprecipitation assays, no nuclease activity were detected in samples reacted with NRS controls (data not shown).
Taken together, results of these coupled immunoprecipitation/activity gel assays demonstrated that each of these parasite isolates synthesized and released/secreted a *35 kDa, DTT-sensitive nuclease activity which appeared to be structurally (i.e., similar in molecular mass and possess conserved antigenic epitopes) and functionally (i.e., similar enzymatic properties) homologous to that previously identified and characterized in the Sudanese isolate of L. donovani [6] .
Immunoprecipitation of the LdNuc s nuclease with sera from visceral leishmaniasis patients Recently, we demonstrated that the LdNuc s gene was both readily transcribed and translated into a functionally active 35 kDa, DTT-sensitive, released/secreted nuclease by both promastigote and axenic amastigote developmental forms of the 1S-CL2D, Sudanese strain of L. donovani parasites [6] . Moreover, in that report we showed that this parasite nuclease was also expressed by in vivo tissue-derived amastigotes isolated directly from acutely infected hamster spleen tissue. In light of those observations, we hypothesized that L. donovani amastigotes might synthesize and release/secrete an LdNuc s nuclease during course of human visceral infections. Further, we speculated that if such in vivo amastigotes produced this nuclease, then VL-patients should produce antibodies against it. To test this hypothesis, immunoprecipitation experiments were designed using sera obtained from acutely infected visceral leishmaniasis patients. For these experiments, promastigotes of L. donovani (i.e., 1S-CL2D, Sudanese strain) episomally transfected with the LdNuc s -HA chimeric construct [6] were grown in chemically defined medium. The cell-free culture supernatants from these transfectants were used as the source of epitope-tagged LdNuc s -HA nuclease for these immunoprecipitation experiments. Aliquots of such supernatants were reacted with pools of sera from visceral leishmaniasis (VL) patients (i.e., obtained from three geographically distinct endemic foci: Sudan, India and Brazil) in protein A Sepharose bead-based assay as described previously [14] . Bead-bound immunoprecipitates were eluted in SDS-PAGE sample buffer lacking any reducing agent and subsequently analyzed for their nuclease activity using SDS-PAGE zymogram gels. Parallel aliquots of these immunoprecipitates were also subjected to Western blot analyses.
Results of those zymogram analyses showed that the pools of VL-patient sera from India, Sudan and Brazil each immunoprecipitated a single *35 kDa LdNuc s nuclease activity present in the culture supernatants obtained from the LdNuc s -HA-transfected parasites (Fig. 7a, lanes 2-4,  respectively) . In these assays, no nuclease activity was detected in parallel samples reacted with NHS controls Fig. 7a, lane 1) . Virtually identical results were also observed in nuclease activity assays with immunoprecipitates obtained from reactions between the VL-patient sera and culture supernatants from non-transfected, wild-type, 1S-CL2D, Sudanese strain parasites (data not shown). It is of importance to point out that the nuclease activity present in each of these immunoprecipitates above was completely abolished when they were eluted with sample buffer containing DTT (data not shown). To verify that the nuclease activities immunoprecipitated by the VL-patient sera were in fact due to the LdNuc s -HA expressed protein, such immunoprecipitates were also subjected SDS-PAGE, trans-blotted onto PVDF membranes and analyzed in Western blots using an anti-HA antibody. Results of those analyses showed that the anti-HA antibody recognized the single 35 kDa LdNuc s -HA nuclease present in the immunoprecipitates obtained with each of the VL-patient sera pools (i.e., from India, Sudan and Brazil, Fig. 7b, lanes 2-4, respectively) . Parallel samples reacted with NHS controls showed no reactivity with the anti-HA antibody (Fig. 7b, lane 1) .
Taken together, results of these coupled immunoprecipitation/zymogram activity gel assays in conjunction with those of our Western blot analyses demonstrated that each of the VL-patient sera pools possessed antibodies that specifically recognized the 35-kDa, DTT-sensitive, parasite-released/secreted LdNuc s nuclease.
Discussion
Collectively, various species of the pathogenic protozoan parasite genus Leishmania are responsible for causing in excess of 2 million new cases of human disease per year worldwide. Importantly, over 500,000 of these cases are caused by either L. donovani or L. infantum, the etiologic agents of fatal human visceral leishmaniasis [19] . Leishmania, like other trypanosomatid parasites, are completely incapable of synthesizing the purine ring de novo and consequently are considered strict purine auxotrophs [4, 5] . Therefore, these parasites are totally dependent upon their hosts to provide them with these essential pre-formed compounds. Thus, these organisms have evolved salvage mechanisms to both access and acquire host-derived purines which are critical for their survival, growth and development. In that regard, recently we identified and characterized a gene (LdNuc s ) encoding a unique, Class-I, ''secretory'' nuclease from a Sudanese strain (1S-CL2D) of L. donovani [6] . In that report, we showed that the LdNuc s gene encoded a *35 kDa, DTT-sensitive nuclease that was synthesized and released/secreted by both in vitrogrown promastigote and axenic amastigote developmental forms of this parasite. Importantly, the LdNuc s nuclease was also found to be expressed by in vivo-derived amastigotes isolated from spleen tissues of experimentally infected hamsters. Moreover, using a variety of molecular-, biochemical-and coupled-immunochemical approaches, we demonstrated that the LdNuc s nuclease could readily hydrolyze various synthetic polynucleotides as well as, several natural nucleic acid substrates including RNA, single-and double-stranded DNAs [6] . In that report, it was concluded that LdNuc s must play a critical role in purine salvage pathways in these human pathogens. Antibody and gene probes generated in that study provided highly specific reagents to ascertain whether LdNuc s homologs might also be present in other geographically disparate human isolates/strains of L. donovani or in L. infantum parasites. Thus in the current study, we used a full length LdNuc s gene probe to demonstrate that such homologs were in fact present in the genomes of each of the several different geographic isolates of L. donovani tested as well as in L. infantum. Results of our RT-PCR analyses showed that these LdNuc s gene homologs were transcribed into mature mRNA messages by each of these viscerotropic parasite lines. Further, nt-sequencing of such RT-PCR products and their ClustalW analyses demonstrated that the LdNuc s gene sequences were highly conserved (i.e., *99% identity) among the Leishmania spp. examined here. Such a high level of structural conservation suggests that this enzyme must play an important role in parasite survival. Results of Western blots with an anti-LdNuc s peptide-specific antibody showed that these LdNuc s gene homologs were expressed as a *35 kDa protein in each of the parasites lines analyzed. In addition, those results also indicated that each of the LdNuc s protein homologs possessed/contained ''common'' antigenic peptide-epitopes presumably reflecting a high level of amino acid sequence conservation among each of them. In parallel, results of in situ activity gel zymogram analyses also showed that each of these viscerotopic parasite lines synthesized and released/secreted a *35 kDa nuclease activity into their culture supernatants during their growth in vitro. Further, each of those *35 kDa nuclease activity homologs was readily immunoprecipitated with the anti-LdNuc s peptide antibody. Results of coupled immunoprecipitation in situ zymogram activity gel analyses demonstrated that each of these *35 kDa nuclease homologs was in fact a DTT-sensitive nuclease. Cumulatively, the functional conservation of this enzyme among these geographic isolates further emphasizes that LdNuc s must play an essential role in purine acquisition by these parasites.
In our opinion, one of the most significant observations made during the course of these studies was the finding that sera from acutely infected visceral leishmaniasis patients from India, Sudan and Brazil all recognized and immunoprecipitated the LdNuc s -HA-expressed nuclease enzyme. These results strongly suggest that this enzyme is synthesized and expressed by in vivo amastigotes during the course of these human infections. Thus, this parasite nuclease must have a role(s) in the survival, growth and development of these organisms during the course of these human diseases. Further, our observations suggest that the LdNuc s might represent a logical target for future chemoor immunotherapeutic intervention against this important group of human pathogens. However, this hypothesis remains to be tested experimentally.
